Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination (VITAMIN)
Viral Immunity in TrAnsplanted Patients Depending on iMmunosupressIon
Sponsor: National Agency for Research on AIDS and Viral Hepatitis (ANRS)
Listed as NCT06307808, this observational or N/A phase trial focuses on HBV and Kidney Transplantation and remains ongoing. Sponsored by National Agency for Research on AIDS and Viral Hepatitis (ANRS), it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Nov 2025 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Mar 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Agency for Research on AIDS and Viral Hepatitis (ANRS)
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .